Related Experiment Videos
Lessons from the "Euro-Lupus Cohort"
Ricard Cervera1, M Abarca-Costalago, D Abramovicz
1Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spain. rcervera@clinic.ub.es
Annales De Medecine Interne
|March 1, 2003
Summary
The Euro-Lupus Cohort study tracks 1,000 patients with systemic lupus erythematosus (SLE) to understand disease progression and identify prognostic factors. This research offers updated insights into SLE morbidity and mortality. Keywords: Systemic Lupus Erythematosus, SLE, Euro-Lupus Cohort, prognostic factors, morbidity, mortality.
Area of Science:
- Rheumatology
- Clinical Immunology
- Epidemiology
Background:
- The Euro-Lupus Cohort, established in 1991, comprises 1,000 patients with systemic lupus erythematosus (SLE).
- It was initiated by the Euro-Lupus Project Group, part of the European Working Party on SLE network.
- The cohort aims to advance research on SLE in Europe.
Purpose of the Study:
- To provide current data on SLE morbidity and mortality characteristics.
- To identify clinical and immunological factors that predict disease prognosis.
- To enhance understanding of SLE progression and outcomes.
Main Methods:
- Prospective follow-up of 1,000 SLE patients since 1991.
- Data collection by a European consortium (Euro-Lupus Project Group).
- Analysis of clinical and immunological data to determine prognostic significance.
Main Results:
- The cohort provides updated information on SLE morbidity and mortality trends.
- Key clinical and immunological prognostic factors for SLE have been defined.
- Long-term prospective data allows for robust analysis of disease outcomes.
Conclusions:
- The Euro-Lupus Cohort is a valuable resource for understanding contemporary SLE characteristics.
- Identification of prognostic factors aids in personalized patient management and treatment strategies.
- Continued research using this cohort will further elucidate SLE pathogenesis and outcomes.